The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Explore Jazz Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for JAZZ. Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize ...

Every week during the regular season begins here at SCH with the Salt City Seven, a septet of recurring features that let us relive the biggest moments, key performances and hot issues in Jazzland ...

Explore the Windy City through tracks by Ramsey Lewis, Ahmad Jamal, Lester Bowie and the contemporary artists at the ...

Dublin, Ireland-based Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus on neuroscience and oncology. JAZZ is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Fintel reports that on March 7, 2025, UBS upgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) from Neutral to Buy. As of March 4, 2025, the average one-year price target for Jazz ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings tomorrow after the bell. Here’s what to look for. Jazz Pharmaceuticals beat analysts’ revenue expectations by 1. ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...